Live probiotic supplements dominate gut health shelf space, but immunologist Dr. Jenna Macciochi argues operators and shoppers are fixating on the wrong delivery format — and her reasoning carries real implications for finished-formulation strategy.
Macciochi, whose work sits at the intersection of nutrition science and immunology, contends that colony-forming unit (CFU) counts and live-culture marketing obscure a more fundamental question: whether the microorganisms survive transit to the colon in meaningful numbers. Most encapsulation technologies still struggle with gastric acid degradation, and ambient storage further reduces viable counts long before the product reaches the consumer. That survivability gap, she argues, is where prebiotics and postbiotics hold a structural advantage.
The Stability Argument
Prebiotics — non-digestible fibers and substrates such as inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS) — feed established microbial communities already resident in the gut rather than introducing new strains that must compete, colonize, and survive. Because they are not live organisms, they require no cold chain, carry no viability loss on shelf, and are considerably easier to incorporate into functional food and beverage formats at meaningful doses. From a formulation standpoint, that opens distribution channels — ambient grocery, foodservice, e-commerce — that refrigerated probiotic SKUs cannot easily reach.
Postbiotics present a related case. Defined by the International Scientific Association for Probiotics and Prebiotics (ISAPP) as preparations of inanimate microorganisms and/or their components that confer a health benefit on the host, postbiotics sidestep the live-culture viability problem entirely. Heat-treated or fermentation-derived, they are shelf-stable, scalable, and — critically — their bioactive compounds are already present at a fixed concentration, making structure-function claim substantiation more straightforward than with live strains whose activity varies by batch and storage condition.
Market Context
The gut health supplement and functional food category is one of the fastest-growing segments in the broader nutraceuticals market, with demand accelerating alongside mainstream awareness of the microbiome's role in immunity, metabolic health, and even mood. That macro tailwind has attracted crowded shelves and an increasingly skeptical retail buyer community looking for clinical differentiation beyond CFU count. Macciochi's framing — prioritizing mechanism over marketing — aligns with a broader industry pivot toward evidence-based positioning and away from "more cultures" as the primary selling point.
For ingredient suppliers, the guidance reinforces commercial momentum already building around prebiotic fibers and next-generation postbiotic ingredients. For brand formulators, it underscores the value of substrate specificity: not all prebiotics feed the same microbial genera, and not all postbiotic preparations deliver the same bioactive profile. Dose, matrix compatibility, and clinical endpoint data are becoming table-stakes for buyers at specialty retail and beyond.
Operators evaluating gut health positioning for functional beverage or snack formats will find the stability and ambient-distribution advantages of prebiotics and postbiotics particularly relevant as the category pushes further into foodservice and convenience channels.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.
